aap Implantate received a funding commitment of up to €0.7 million (~USD $0.8 million) for conception and qualification of a human clinical study to support market approval of its antibacterial silver coating technology.
The company still needs approval from the ethics commissions in Germany before the study can begin. Participating physicians have been trained and equipment (silver-coated implants) has been prepared at corresponding clinics.
The grant is part of BMBF’s Health Industry in the Health Research Framework Programme, whereby funding will be offered for projects that fall under “Transferring medical technology solutions into patient care – proving clinical evidence without delay.” The purpose of the program is to introduce small and medium-sized enterprises to changing legal and regulatory conditions and support them in the clinical validation of medical technology solutions.
aap Implantate received a funding commitment of up to €0.7 million (~USD $0.8 million) for conception and qualification of a human clinical study to support market approval of its antibacterial silver coating technology.
aap Implantate received a funding commitment of up to €0.7 million (~USD $0.8 million) for conception and qualification of a human clinical study to support market approval of its antibacterial silver coating technology.
The company still needs approval from the ethics commissions in Germany before the study can begin. Participating physicians have been trained and equipment (silver-coated implants) has been prepared at corresponding clinics.
The grant is part of BMBF’s Health Industry in the Health Research Framework Programme, whereby funding will be offered for projects that fall under “Transferring medical technology solutions into patient care – proving clinical evidence without delay.” The purpose of the program is to introduce small and medium-sized enterprises to changing legal and regulatory conditions and support them in the clinical validation of medical technology solutions.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.
Copy to clipboard 
